Literature DB >> 3008892

Analysis of the peptide subunits of human neutrophil myeloperoxidase.

W M Nauseef, H L Malech.   

Abstract

Myeloperoxidase is a cationic protein present in the azurophilic granules of human neutrophils and constitutes 2% to 5% of neutrophil protein by weight. Despite extensive characterization of the functional importance of myeloperoxidase in the microbicidal activity of neutrophils, there is no consensus regarding the subunit composition of this enzyme or the presence of genetic polymorphism. Using isoelectric focussing and peptide mapping of chymotryptic digests of myeloperoxidase subunits under reducing and nonreducing conditions, we found two different heavy chain peptides that have overlapping but distinctive chymotryptic digest maps. One of these heavy chains has a reducible intrapeptide disulfide bond not found in the other. These results suggest that the model proposed for the structure of myeloperoxidase as a symmetric molecule with two identical heavy-light protomers may not be correct.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3008892

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Oxidative stress versus antioxidant defenses in patients with acute myocardial infarction.

Authors:  Margarete Dulce Bagatini; Caroline Curry Martins; Vanessa Battisti; Diogo Gasparetto; Cintia Saydelles da Rosa; Roselia Maria Spanevello; Mushtaq Ahmed; Roberta Schmatz; Maria Rosa Chitolina Schetinger; Vera Maria Morsch
Journal:  Heart Vessels       Date:  2010-10-27       Impact factor: 2.037

2.  Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein-Kinin system.

Authors:  Joshua M Astern; William F Pendergraft; Ronald J Falk; J Charles Jennette; Alvin H Schmaier; Fakhri Mahdi; Gloria A Preston
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

Review 3.  The use of myeloperoxidase as a risk marker for atherosclerosis.

Authors:  Vijay Nambi
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

4.  Immunological detection of myeloperoxidase in synovial fluid from patients with rheumatoid arthritis.

Authors:  S W Edwards; V Hughes; J Barlow; R Bucknall
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

5.  Emerging Role of Myeloperoxidase in the Prognosis of Nephrotic Syndrome Patients Before and After Steroid Therapy.

Authors:  Sreelatha Souparnika; Benedicta D'Souza; Vivian D'Souza; Sushanth Kumar; Poornima Manjrekar; Manohar Bairy; Rajeevalochana Parthasarathy; Srinivas Kosuru
Journal:  J Clin Diagn Res       Date:  2015-07-01

6.  Evaluation of the serum catalase and myeloperoxidase activities in chronic arsenic-exposed individuals and concomitant cytogenetic damage.

Authors:  Mayukh Banerjee; Nilanjana Banerjee; Pritha Ghosh; Jayanta K Das; Santanu Basu; Ajoy K Sarkar; J Christopher States; Ashok K Giri
Journal:  Toxicol Appl Pharmacol       Date:  2010-08-20       Impact factor: 4.219

7.  cDNA cloning of human myeloperoxidase: decrease in myeloperoxidase mRNA upon induction of HL-60 cells.

Authors:  S C Weil; G L Rosner; M S Reid; R L Chisholm; N M Farber; J K Spitznagel; M S Swanson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

8.  Potential role of tryptophan and chloride in the inhibition of human myeloperoxidase.

Authors:  Semira Galijasevic; Ibrahim Abdulhamid; Husam M Abu-Soud
Journal:  Free Radic Biol Med       Date:  2008-01-18       Impact factor: 7.376

9.  Anti-myeloperoxidase autoantibodies react with native but not denatured myeloperoxidase.

Authors:  R J Falk; M Becker; R Terrell; J C Jennette
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

Review 10.  Oxidative risk for atherothrombotic cardiovascular disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.